NYSE:ENFN Enfusion (ENFN) Stock Price, News & Analysis $11.05 -0.04 (-0.36%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Enfusion Stock (NYSE:ENFN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Enfusion alerts:Sign Up Key Stats Today's Range$11.01▼$11.1050-Day Range$9.63▼$11.1552-Week Range$7.52▼$11.38Volume717,859 shsAverage Volume1.34 million shsMarket Capitalization$1.42 billionP/E Ratio276.32Dividend YieldN/APrice Target$10.25Consensus RatingReduce Company OverviewEnfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.Read More… Enfusion Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks48th Percentile Overall ScoreENFN MarketRank™: Enfusion scored higher than 48% of companies evaluated by MarketBeat, and ranked 422nd out of 674 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.9 / 5Analyst RatingReduce Consensus RatingEnfusion has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on 2 buy ratings, 2 hold ratings, and 3 sell ratings.Amount of Analyst CoverageEnfusion has only been the subject of 3 research reports in the past 90 days.Read more about Enfusion's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth133.33% Earnings GrowthEarnings for Enfusion are expected to grow by 133.33% in the coming year, from $0.06 to $0.14 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Enfusion is 276.32, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 110.72.Price to Earnings Ratio vs. SectorThe P/E ratio of Enfusion is 276.32, which means that it is trading at a more expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 232.79.Price to Earnings Growth RatioEnfusion has a PEG Ratio of 1.81. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioEnfusion has a P/B Ratio of 18.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Enfusion's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.13% of the float of Enfusion has been sold short.Short Interest Ratio / Days to CoverEnfusion has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Enfusion has recently decreased by 31.40%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEnfusion does not currently pay a dividend.Dividend GrowthEnfusion does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.13% of the float of Enfusion has been sold short.Short Interest Ratio / Days to CoverEnfusion has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Enfusion has recently decreased by 31.40%, indicating that investor sentiment is improving significantly. News and Social Media1.8 / 5News SentimentN/A News SentimentEnfusion has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.64 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 1 news article for Enfusion this week, compared to 3 articles on an average week.Search Interest2 people have searched for ENFN on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership4.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Enfusion insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $591,335.00 in company stock.Percentage Held by Insiders36.44% of the stock of Enfusion is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions81.05% of the stock of Enfusion is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Enfusion's insider trading history. Receive ENFN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enfusion and its competitors with MarketBeat's FREE daily newsletter. Email Address ENFN Stock News HeadlinesEnfusion, Inc. (NYSE:ENFN) Director Sells $17,237.61 in StockJanuary 16, 2025 | insidertrades.comEnfusion, Inc. (NYSE:ENFN) CEO Oleg Movchan Sells 2,771 SharesJanuary 11, 2025 | insidertrades.comThis Indicator called BOTH NVDA ralliesRarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… January 27, 2025 | ProsperityPub (Ad)Insider Selling: Enfusion, Inc. (NYSE:ENFN) CFO Sells 24,443 Shares of StockDecember 27, 2024 | insidertrades.comWilliam Blair downgrades Enfusion (ENFN) to a HoldJanuary 18, 2025 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN and ITCI on Behalf of ShareholdersJanuary 16, 2025 | prnewswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN and EDBL on Behalf of ShareholdersJanuary 15, 2025 | globenewswire.comEnfusion downgraded to Hold from Buy at StifelJanuary 14, 2025 | finance.yahoo.comSee More Headlines ENFN Stock Analysis - Frequently Asked Questions How have ENFN shares performed this year? Enfusion's stock was trading at $10.30 at the beginning of the year. Since then, ENFN shares have increased by 7.3% and is now trading at $11.05. View the best growth stocks for 2025 here. How were Enfusion's earnings last quarter? Enfusion, Inc. (NYSE:ENFN) issued its quarterly earnings data on Thursday, May, 9th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by $0.05. The business earned $48.05 million during the quarter, compared to analyst estimates of $47.67 million. Enfusion had a trailing twelve-month return on equity of 6.67% and a net margin of 1.70%. When did Enfusion IPO? Enfusion (ENFN) raised $300 million in an IPO on Thursday, October 21st 2021. The company issued 18,750,000 shares at a price of $15.00-$17.00 per share. Who are Enfusion's major shareholders? Enfusion's top institutional shareholders include SG Americas Securities LLC (0.02%), Lake Street Private Wealth LLC (0.01%) and Harbor Capital Advisors Inc. (0.01%). Insiders that own company stock include Neal Pawar, Oleg Movchan, Bronwen Bastone, Dan Groman, Matthew Campobasso, Deirdre Somers, Valeria Gutowski, Tarek Hammoud and Stephen Malherbe. View institutional ownership trends. How do I buy shares of Enfusion? Shares of ENFN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Enfusion own? Based on aggregate information from My MarketBeat watchlists, some other companies that Enfusion investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Alphabet (GOOG). Company Calendar Last Earnings5/09/2024Today1/27/2025Next Earnings (Estimated)3/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry Prepackaged software Sub-IndustryComputer Software Current SymbolNYSE:ENFN CUSIPN/A CIK1868912 Webwww.enfusion.com Phone312-253-9800FaxN/AEmployees1,102Year FoundedN/APrice Target and Rating Average Stock Price Target$10.25 High Stock Price Target$13.00 Low Stock Price Target$8.00 Potential Upside/Downside-7.2%Consensus RatingReduce Rating Score (0-4)1.86 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)$0.04 Trailing P/E Ratio276.32 Forward P/E Ratio184.17 P/E Growth1.81Net Income$6.03 million Net Margins1.70% Pretax Margin3.64% Return on Equity6.67% Return on Assets4.86% Debt Debt-to-Equity RatioN/A Current Ratio3.62 Quick Ratio3.62 Sales & Book Value Annual Sales$174.54 million Price / Sales8.14 Cash Flow$0.14 per share Price / Cash Flow77.08 Book Value$0.61 per share Price / Book18.11Miscellaneous Outstanding Shares128,570,000Free Float81,720,000Market Cap$1.42 billion OptionableOptionable Beta0.95 Social Links The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NYSE:ENFN) was last updated on 1/27/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enfusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enfusion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.